Brand name authorized in: Australia Cyprus Spain Finland France Ireland Netherlands Singapore United Kingdom United States
The drug ABSTRAL contains one active pharmaceutical ingredient (API):
Fentanyl is a potent µ-opioid analgesic with rapid onset of analgesia and short duration of action. Its primary therapeutic actions are analgesia and sedation and is approximately 100-fold more potent than morphine as an analgesic. Secondary effects of fentanyl on central nervous system (CNS), respiratory and gastro-intestinal function are typical of opioid analgesics and are considered to be class effects.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
Below package inserts are available for further reading:
This drug has been assigned below unique identifiers within the countries it is being marketed: